Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Nivolumab and Bendamustine in R/R Hodgkin's Lymphoma
NCT03343652Phase 2Completed
- Sponsor
- First Saint Petersburg State Medical University
- Start
- May 2017
- Primary completion
- Mar 2019
- Modality
- Small Molecules, Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 2 trial of nivolumab, bendamustine in Hodgkin lymphoma (HL), sponsored by First Saint Petersburg State Medical University. Started May 2017; status: completed.
02
Drugs
nivolumabbendamustine
03
Conditions
Hodgkin lymphoma (HL)
Beyond the preview
Go deeper on NCT03343652.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03343652.